Regeneron Pharmaceuticals Overview

Life ScienceCompany

Where is Regeneron Pharmaceuticals headquartered?

Regeneron Pharmaceuticals is headquartered in Tarrytown, New York.

What is Regeneron Pharmaceuticals’ revenue?

Regeneron Pharmaceuticals disclosed revenue of 14,202M USD for 2024 and 13,117M USD for 2023.

How many employees does Regeneron Pharmaceuticals have?

Regeneron Pharmaceuticals has 15,106 employees.

What sector is Regeneron Pharmaceuticals in?

Regeneron Pharmaceuticals is a life science company.

When was Regeneron Pharmaceuticals founded?

Regeneron Pharmaceuticals was founded in 1988.

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc.

777 Old Saw Mill River Road,
Tarrytown, New York 10591
United States,
(914) 347-7000
www.regeneron.com

Regeneron Pharmaceuticals is a biopharmaceutical company based that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition, and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis. Regeneron Pharmaceuticals was founded in 1988 and is based in Tarrytown, New York.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.4/yr) # - - 1 1 - - 2
vol $250M $109M $359M
Sell (0.0/yr) # - - - - - - 0
  2

Top M&A Advisors

Legal Deals
Wachtell, Lipton, Rosen & Katz
2

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.